FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Georg Maschmeyer

Research Profile

Procedures

Chemicals & Drugs

Disorders

Concepts & Ideas

Co-author Network

Publications

TOP 3
S Neumann; X Schiel; M von Lilienfeld-Toal; S W Krause; Georg Maschmeyer
Primary prophylaxis of bacterial infections and Pneumocystis jirovecii pneumonia in patients with hematological malignancies and solid tumors : guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO).
Maria J G T Vehreschild; Marie von Lilienfeld-Toal; Mohammed Wattad; Hildegard Christ; Oliver Andreas Cornely; Martin Hellmich; Meinholf Karthaus; Georg Maschmeyer; Arne M K Meissner; Silke Neumann; Peter Staib; Jörg Vehreschild
Clinically defined chemotherapy-associated bowel syndrome predicts severe complications and death in cancer patients.
M J G T Rüping; W J Heinz; A J Kindo; V Rickerts; C Lass-Flörl; C Beisel; Raoul Herbrecht; Y Roth; Gerda Silling; Andrew J Ullmann; K Borchert; Gerlinde Egerer; Johan Maertens; Georg Maschmeyer; A Simon; M Wattad; G Fischer; Jörg Vehreschild; Oliver A Cornely
Forty-one recent cases of invasive zygomycosis from a global clinical registry.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Georg Maschmeyer (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: S Neumann; X Schiel; M von Lilienfeld-Toal; S W Krause; Georg Maschmeyer
Primary prophylaxis of bacterial infections and Pneumocystis jirovecii pneumonia in patients with hematological malignancies and solid tumors : guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO).
Annals of hematology 2013;92(4):433-42.
2011: Maria J G T Vehreschild; Marie von Lilienfeld-Toal; Mohammed Wattad; Hildegard Christ; Oliver Andreas Cornely; Martin Hellmich; Meinholf Karthaus; Georg Maschmeyer; Arne M K Meissner; Silke Neumann; Peter Staib; Jörg Vehreschild
Clinically defined chemotherapy-associated bowel syndrome predicts severe complications and death in cancer patients.
Haematologica 2011;96(12):1855-60.
2010: M J G T Rüping; W J Heinz; A J Kindo; V Rickerts; C Lass-Flörl; C Beisel; Raoul Herbrecht; Y Roth; Gerda Silling; Andrew J Ullmann; K Borchert; Gerlinde Egerer; Johan Maertens; Georg Maschmeyer; A Simon; M Wattad; G Fischer; Jörg Vehreschild; Oliver A Cornely
Forty-one recent cases of invasive zygomycosis from a global clinical registry.
The Journal of antimicrobial chemotherapy 2010;65(2):296-302.
2009: Jörg Vehreschild; Michal Sieniawski; Stefan Reuter; Dorothee Arenz; Dietmar Reichert; Johan Maertens; Angelika Böhme; Gerda Silling; Rodrigo Martino; Georg Maschmeyer; Maria J G T Rüping; Andrew J Ullmann; Oliver A Cornely
Efficacy of caspofungin and itraconazole as secondary antifungal prophylaxis: analysis of data from a multinational case registry.
International journal of antimicrobial agents 2009;34(5):446-50.
2009: Oliver A Cornely; Angelika Böhme; Dieter Buchheidt; Hermann Einsele; Werner J Heinz; Meinolf Karthaus; Stefan W Krause; William Krüger; Georg Maschmeyer; Olaf Penack; Jörg Ritter; Markus Ruhnke; Michael Sandherr; Michal Sieniawski; Jörg Vehreschild; Hans-Heinrich Wolf; Andrew J Ullmann
Primary prophylaxis of invasive fungal infections in patients with hematologic malignancies. Recommendations of the Infectious Diseases Working Party of the German Society for Haematology and Oncology.
Haematologica 2009;94(1):113-22.
2009: Thomas Büchner; Wolfgang E Berdel; Claudia Haferlach; Torsten Haferlach; Susanne Schnittger; Carsten Müller-Tidow; Jan Braess; Karsten Spiekermann; Joachim Kienast; Peter Staib; Andreas Grüneisen; Wolfgang Kern; Albrecht Reichle; Georg Maschmeyer; Carlo Aul; Eva Lengfelder; Maria Cristina Sauerland; Achim Heinecke; Bernhard Wörmann; Wolfgang Hiddemann
Age-related risk profile and chemotherapy dose response in acute myeloid leukemia: a study by the German Acute Myeloid Leukemia Cooperative Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(1):61-9.
2008: Hans-Heinrich Wolf; Malte Leithäuser; Georg Maschmeyer; Hans Salwender; Ulrike Klein; Iris F Chaberny; Florian Weissinger; Dieter Buchheidt; Markus Ruhnke; Gerlinde Egerer; Oliver Cornely; Gerd Fätkenheuer; Sabine Mousset
Central venous catheter-related infections in hematology and oncology : guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO).
Annals of hematology 2008;87(11):863-76.
2008: Oliver A Cornely; Angelika Böhme; Dietmar Reichert; Stefan Reuter; Georg Maschmeyer; Johan Maertens; Dieter Buchheidt; Monika Paluszewska; Dorothee Arenz; Ullrich Bethe; Jenny Effelsberg; Harry Lövenich; Michal Sieniawski; Antje Haas; Hermann Einsele; Hartmut Eimermacher; Rodrigo Martino; Gerda Silling; Moritz Hahn; Sidonie Wacker; Andrew J Ullmann; Meinolf Karthaus
Risk factors for breakthrough invasive fungal infection during secondary prophylaxis.
The Journal of antimicrobial chemotherapy 2008;61(4):939-46.
2008: Georg Maschmeyer; Antje Haas
The epidemiology and treatment of infections in cancer patients.
International journal of antimicrobial agents 2008;31(3):193-7.
2007: Georg Maschmeyer; Antje Haas; Oliver A Cornely
Invasive aspergillosis: epidemiology, diagnosis and management in immunocompromised patients.
Drugs 2007;67(11):1567-601.
2006: Georg Maschmeyer; Antje Haas
Voriconazole: a broad spectrum triazole for the treatment of serious and invasive fungal infections.
Future microbiology 2006;1(4):365-85.
2006: Xaver Schiel; H Link; Georg Maschmeyer; Bertram Glaß; Oliver A Cornely; Dieter Buchheidt; M Wilhelm; Gerda Silling; M Helmerking; Wolfgang Hiddemann; Helmut Ostermann; Marcus Hentrich
A prospective, randomized multicenter trial of the empirical addition of antifungal therapy for febrile neutropenic cancer patients: results of the Paul Ehrlich Society for Chemotherapy (PEG) Multicenter Trial II.
Infection 2006;34(3):118-26.
2006: Georg Maschmeyer
The changing epidemiology of invasive fungal infections: new threats.
International journal of antimicrobial agents 2006;27 Suppl 1():3-6.
2006: Stefan Neuburger; Georg Maschmeyer
Update on management of infections in cancer and stem cell transplant patients.
Annals of hematology 2006;85(6):345-56.
2006: Robert Betts; Axel Glasmacher; Johan Maertens; Georg Maschmeyer; Jose A Vazquez; Hedy Teppler; Arlene Taylor; Robert J Lupinacci; Carole A Sable; Nicholas A Kartsonis
Efficacy of caspofungin against invasive Candida or invasive Aspergillus infections in neutropenic patients.
Cancer 2006;106(2):466-73.
2005: Jörg Westermann; Georg Maschmeyer; Antje van Lessen; Bernd Dörken; Antonio Pezzutto
CD52 is not a promising immunotherapy target for most patients with multiple myeloma.
International journal of hematology 2005;82(3):248-50.
2005: Gernot Reich; Oliver A Cornely; Michael Sandherr; Thomas Kubin; Stefan Krause; Hermann Einsele; Eckhard Thiel; Tanja Bellaire; Bernd Dörken; Georg Maschmeyer
Empirical antimicrobial monotherapy in patients after high-dose chemotherapy and autologous stem cell transplantation: a randomised, multicentre trial.
British journal of haematology 2005;130(2):265-70.
2005: Georg Maschmeyer; Axel Glasmacher
Pharmacological properties and clinical efficacy of a recently licensed systemic antifungal, caspofungin.
Mycoses 2005;48(4):227-34.
2005: Georg Maschmeyer; A Haas; Angelika Böhme
[Update on therapy of invasive mycoses in hematology and oncology].
Deutsche medizinische Wochenschrift (1946) 2005;130(22):1381-4.
2005: Georg Maschmeyer
Management of vancomycin-resistant enterococci--a paradigm.
Onkologie 2005;28(4):183-4.
2004: Uta Zaspel; David W Denning; Arne-Jörn Lemke; Reginald Greene; Dirk Schürmann; Georg Maschmeyer; Markus Ruhnke; Raoul Herbrecht; Patricia Ribaud; Olivier Lortholary; Harmien Zonderland; Klaus F Rabe; Rainer Röttgen; Roland Bittner; Klaus Neumann; Jörg Oestmann
Diagnosis of IPA in HIV: the role of the chest X-ray and radiologist.
European radiology 2004;14(11):2030-7.
2004: Thomas Büchner; Wolfgang Hiddemann; Wolfgang E Berdel; Bernhard Wörmann; Claudia Schoch; Christa Fonatsch; Helmut Löffler; Torsten Haferlach; Wolf-Dieter Ludwig; Georg Maschmeyer; Peter Staib; Leopold Balleisen; Andreas Grüneisen; Carlo Aul; Eva Lengfelder; Rüdiger Hehlmann; Wolfgang Kern; Hubert Serve; Rolf M Mesters; Hartmut Eimermacher; Norbert Frickhofen; Joachim Kienast; A Giagounidis; Maria Cristina Sauerland; Achim Heinecke
Subgroup specific therapy effects in AML: AMLCG data.
Annals of hematology 2004;83 Suppl 1():S100-1.
2003: Thomas Büchner; Wolfgang Hiddemann; Wolfgang E Berdel; Bernhard Wörmann; Claudia Schoch; Christa Fonatsch; Helmut Löffler; Torsten Haferlach; Wolf-Dieter Ludwig; Georg Maschmeyer; Peter Staib; Carlo Aul; Andreas Gruneisen; Eva Lengfelder; Norbert Frickhofen; Wolfgang Kern; Hubert Serve; Rolf M Mesters; Maria Cristina Sauerland; Achim Heinecke
6-Thioguanine, cytarabine, and daunorubicin (TAD) and high-dose cytarabine and mitoxantrone (HAM) for induction, TAD for consolidation, and either prolonged maintenance by reduced monthly TAD or TAD-HAM-TAD and one course of intensive consolidation by sequential HAM in adult patients at all ages with de novo acute myeloid leukemia (AML): a randomized trial of the German AML Cooperative Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(24):4496-504.
2003: H Link; Angelika Böhme; Oliver A Cornely; K Höffken; Olaf Kellner; Winfried V Kern; R Mahlberg; Georg Maschmeyer; M R Nowrousian; Helmut Ostermann; Markus Ruhnke; Orhan Sezer; Xaver Schiel; M Wilhelm; Holger Auner
Antimicrobial therapy of unexplained fever in neutropenic patients--guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO), Study Group Interventional Therapy of Unexplained Fever, Arbeitsgemeinschaft Supportivmassnahmen in der Onkologie (ASO) of the Deutsche Krebsgesellschaft (DKG-German Cancer Society).
Annals of hematology 2003;82 Suppl 2():S105-17.
2003: Georg Maschmeyer; Thomas Beinert; Dieter Buchheidt; Hermann Einsele; Claus Peter Heussel; Michael Kiehl; Joachim Lorenz
Diagnosis and antimicrobial therapy of pulmonary infiltrates in febrile neutropenic patients--guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO).
Annals of hematology 2003;82 Suppl 2():S118-26.
2003: Angelika Böhme; Markus Ruhnke; Dieter Buchheidt; Meinolf Karthaus; Hermann Einsele; Stefan Guth; Gudula Heussel; Claus Peter Heussel; Christian Junghanss; Winfried K Kern; Thomas Kubin; Georg Maschmeyer; Orhan Sezer; Gerda Silling; Thomas Südhoff; Hubert Szelényi Dagger; Andrew J Ullmann
Treatment of fungal infections in hematology and oncology--guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO).
Annals of hematology 2003;82 Suppl 2():S133-40.
2003: Hartmut Bertz; Holger Auner; Florian Weissinger; Hans Salwender; Hermann Einsele; Gerlinde Egerer; Michael Sandherr; Silke Schüttrumpf; Thomas Südhoff; Georg Maschmeyer
Antimicrobial therapy of febrile complications after high-dose chemo-/radiotherapy and autologous hematopoietic stem cell transplantation--guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO).
Annals of hematology 2003;82 Suppl 2():S167-74.
2003: Hermann Einsele; Hartmut Bertz; Jörg Beyer; Michael Kiehl; Volker Runde; Hans-Jochen Kolb; Ernst Holler; Robert Beck; Rainer Schwerdfeger; Ulrike Schumacher; Holger Hebart; Hans Martin; Joachim Kienast; Andrew J Ullmann; Georg Maschmeyer; William Krüger; Dietger Niederwieser; Hartmut Link; Christian A Schmidt; Helmut Oettle; Thomas Klingebiel
Infectious complications after allogeneic stem cell transplantation: epidemiology and interventional therapy strategies--guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO).
Annals of hematology 2003;82 Suppl 2():S175-85.
2003: Oliver A Cornely; Angelika Böhme; Dieter Buchheidt; Axel Glasmacher; Christoph Kahl; Meinolf Karthaus; Winfried Kern; William H Krüger; Georg Maschmeyer; Jörg Ritter; Hans Salwender; Michael Sandherr; Xaver Schiel; Silke Schüttrumpf; Michal Sieniawski; Gerda Silling; Andrew J Ullmann; Hans-Heinrich Wolf
Prophylaxis of invasive fungal infections in patients with hematological malignancies and solid tumors--guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO).
Annals of hematology 2003;82 Suppl 2():S186-200.
2003: Georg Maschmeyer; F-L Bertschat; K T Moesta; E Häusler; T K Held; M Nolte; K-J Osterziel; V Papstein; M Peters; Gernot Reich; M Schmutzler; O Sezer; M Stula; H Wauer; T Wörtz; M Wischnewsky; P Hohenberger
Outcome analysis of 189 consecutive cancer patients referred to the intensive care unit as emergencies during a 2-year period.
European journal of cancer (Oxford, England : 1990) 2003;39(6):783-92.
2003: Andreas H Groll; Juan Gea-Banacloche; Axel Glasmacher; Gudrun Just-Nuebling; Georg Maschmeyer; THOMAS WALSH
Clinical pharmacology of antifungal compounds.
Infectious disease clinics of North America 2003;17(1):159-91, ix.
2002: Dieter Hoelzer; Renate Arnold; Claus R Bartram; Angelika Böhme; M Freund; Arnold Ganser; Michael Kneba; Thomas Lipp; Wolf-Dieter Ludwig; Georg Maschmeyer; Harald Rieder; Eckhard Thiel; D Messerer; A Weiss; Nicola Gökbuget
[Acute lymphatic leukemia in the adult. Diagnosis, risk groups and therapy].
Der Internist 2002;43(10):1212-6, 1219-22, 1224-7.
2002: Thomas Büchner; Wolfgang Fegeler; Hannelore Bernhardt; N Brockmeyer; K-H Duswald; M Herrmann; D Heuser; U Jehn; Gudrun Just-Nübling; Meinolf Karthaus; Georg Maschmeyer; F-M Müller; J Müller; J Ritter; N Roos; Markus Ruhnke; A Schmalreck; R Schwarze; Günther Schwesinger; Gerda Silling
Treatment of severe Candida infections in high-risk patients in Germany: consensus formed by a panel of interdisciplinary investigators.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 2002;21(5):337-52.
2002: Thomas Büchner; Wolfgang Hiddemann; Wolfgang E Berdel; Bernhard Wörmann; Claudia Schoch; Helmut Löffler; Torsten Haferlach; Andrea Schumacher; Peter Staib; Leopold Balleisen; Andreas Grüneisen; Herbert Rasche; Carlo Aul; Axel Heyll; Eva Lengfelder; Wolf-Dieter Ludwig; Georg Maschmeyer; Hartmut Eimermacher; Jochen Karow; Norbert Frickhofen; Wolf-Dietrich Hirschmann; Maria Cristina Sauerland
Acute myeloid leukemia: treatment over 60.
Reviews in clinical and experimental hematology 2002;6(1):46-59; discussion 86-7.
2002: Georg Maschmeyer
New antifungal agents-treatment standards are beginning to grow old.
The Journal of antimicrobial chemotherapy 2002;49(2):239-41.
2001: Hermann Einsele; Hartmut Bertz; Jörg Beyer; Michael Kiehl; Volker Runde; H J Kolb; E Holler; R Beck; R Schwerdfeger; U Schumacher; Holger Hebart; H Martin; Joachim Kienast; A J Ullmann; Georg Maschmeyer; William Krüger; H Link; Christian A Schmidt; Helmut Oettle; T Klingebiel
[Epidemiology and interventional treatment strategies of infectious complications after allogenic stem-cell transplantation].
Deutsche medizinische Wochenschrift (1946) 2001;126(45):1278-84.
2001: Thomas Büchner; Wolfgang Hiddemann; Wolfgang E Berdel; Bernhard Wörmann; Helmut Löffler; Claudia Schoch; Torsten Haferlach; Wolf-Dieter Ludwig; Georg Maschmeyer; Peter Staib; R Andreesen; Leopold Balleisen; Detlef Haase; Hartmut Eimermacher; Carlo Aul; Herbert Rasche; J Uhlig; Andreas Grüneisen; H E Reis; J Hartlapp; Wolf-Dietrich Hirschmann; H J Weh; H J Pielken; Winfried Gassmann; Maria Cristina Sauerland; Achim Heinecke
Remission induction therapy: the more intensive the better?
Cancer chemotherapy and pharmacology 2001;48 Suppl 1():S41-4.
2000: Winfried V Kern; Jörg Beyer; Angelika Böhme; Dieter Buchheidt; Oliver A Cornely; Hermann Einsele; Jens Kisro; William H Krüger; Georg Maschmeyer; Markus Ruhnke; C A Schmidt; S Schwartz; H Szelenyi
[Prophylaxis of infection in neutropenic patients. Guidelines of the Working Party on Infections in Hematology and Oncology].
Deutsche medizinische Wochenschrift (1946) 2000;125(51-52):1582-8.
2000: Georg Maschmeyer; I Braveny
Review of the incidence and prognosis of Pseudomonas aeruginosa infections in cancer patients in the 1990s.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 2000;19(12):915-25.
2000: Nicola Gökbuget; Dieter Hoelzer; Renate Arnold; Angelika Böhme; Claus R Bartram; M Freund; Arnold Ganser; Michael Kneba; W Langer; Thomas Lipp; Wolf-Dieter Ludwig; Georg Maschmeyer; Harald Rieder; Eckhard Thiel; A Weiss; D Messerer
Treatment of Adult ALL according to protocols of the German Multicenter Study Group for Adult ALL (GMALL).
Hematology/oncology clinics of North America 2000;14(6):1307-25, ix.
2000: Thomas Büchner; Wolfgang Hiddemann; Bernhard Wörmann; Helmut Löffler; Wolf-Dieter Ludwig; Claudia Schoch; Torsten Haferlach; Georg Maschmeyer; Peter Staib; Carlo Aul; G A Heyll; Andreas Grüneisen; Herbert Rasche; J H Eimermacher; Leopold Balleisen; H J Pielken; H E Reis; Frank Griesinger; Albrecht Reichle; Maria Cristina Sauerland; Achim Heinecke
Acute myeloid leukemia in adults: is postconsolidation maintenance therapy necessary?
International journal of hematology 2000;72(3):285-9.
1999: Georg Maschmeyer
Interventional antimicrobial therapy in febrile neutropenic patients.
Diagnostic microbiology and infectious disease 1999;34(3):205-12.
1999: Thomas Büchner; Wolfgang Hiddemann; Bernhard Wörmann; Helmut Löffler; Winfried Gassmann; Torsten Haferlach; Christa Fonatsch; Detlef Haase; Claudia Schoch; Dieter K Hossfeld; Eva Lengfelder; Carlo Aul; Axel Heyll; Georg Maschmeyer; Wolf-Dieter Ludwig; Maria Cristina Sauerland; Achim Heinecke
Double induction strategy for acute myeloid leukemia: the effect of high-dose cytarabine with mitoxantrone instead of standard-dose cytarabine with daunorubicin and 6-thioguanine: a randomized trial by the German AML Cooperative Group.
Blood 1999;93(12):4116-24.
1999: Georg Maschmeyer; Thomas Beinert; Dieter Buchheidt; Hermann Einsele; E Holler
[Diagnosis and therapy of lung infiltrates in febrile neutropenic patients. Standard recommendations of the Work Group of Infections in Hematology and Oncology of the German Association of Hematology and Oncology].
Deutsche medizinische Wochenschrift (1946) 1999;124 Suppl 1():S18-23.
1999: Georg Maschmeyer; Bernd Hertenstein; Bertram Glaß; Xaver Schiel
[Interventional antimicrobial therapy for febrile complications after high-dose chemotherapy and autologous stem cell transplantation. Standard recommendations of the Work Group of Infections in Hematology and Oncology of the German Association of Hematology and Oncology].
Deutsche medizinische Wochenschrift (1946) 1999;124 Suppl 1():S9-13.
1999: Nicola Gökbuget; Renate Arnold; Thomas Büchner; M Freund; Winfried Gassmann; Gerhard Heil; Wolfgang Hiddemann; Helmut Löffler; Thomas Lipp; Wolf-Dieter Ludwig; Georg Maschmeyer; Eckhard Thiel; D Messerer; Dieter Hoelzer
[Treatment of adult acute lymphoblastic leukemia].
Praxis 1999;88(10):407-20.
1999: Dieter Buchheidt; Wolfgang Hiddemann; Xaver Schiel; V Kremery; Meinolf Karthaus; J Peter Donnelly; M Wilhelm; Georg Maschmeyer; H Link; D Adam; M Helmerking
European surveillance of infections and risk factors in cancer patients.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 1999;18(2):161-3.
1998: Wolfgang Kern; Carlo Aul; Georg Maschmeyer; R Kuse; A Kerkhoff; A Grote-Metke; Hartmut Eimermacher; Uschi Kubica; Bernhard Wörmann; Thomas Büchner; Wolfgang Hiddemann
Granulocyte colony-stimulating factor shortens duration of critical neutropenia and prolongs disease-free survival after sequential high-dose cytosine arabinoside and mitoxantrone (S-HAM) salvage therapy for refractory and relapsed acute myeloid leukemia. German AML Cooperative Group.
Annals of hematology 1998;77(3):115-22.
1998: Wolfgang Kern; Carlo Aul; Georg Maschmeyer; R Schönrock-Nabulsi; Wolf-Dieter Ludwig; A Bartholomäus; P Bettelheim; Bernhard Wörmann; Thomas Büchner; Wolfgang Hiddemann
Superiority of high-dose over intermediate-dose cytosine arabinoside in the treatment of patients with high-risk acute myeloid leukemia: results of an age-adjusted prospective randomized comparison.
Leukemia 1998;12(7):1049-55.
1998: G Behre; H Link; Georg Maschmeyer; P Meyer; U Paaz; M Wilhelm; Wolfgang Hiddemann
Meropenem monotherapy versus combination therapy with ceftazidime and amikacin for empirical treatment of febrile neutropenic patients.
Annals of hematology 1998;76(2):73-80.
1997: Wolfgang Hiddemann; Georg Maschmeyer; H Link; M Helmerking; D Adam
[Therapy of infections in patients with acute leukemia].
Medizinische Klinik (Munich, Germany : 1983) 1997;92(7):406-9.
1997: Georg Maschmeyer; W Hiddemann; H Link; O A Cornely; Dieter Buchheidt; Bertram Glaß; D Adam
Management of infections during intensive treatment of hematologic malignancies.
Annals of hematology 1997;75(1-2):9-16.
1996: Wolfgang Hiddemann; Georg Maschmeyer; V Runde; H Einsele
[Prevention, diagnosis and therapy of infections in patients with malignant diseases].
Der Internist 1996;37(12):1212-24.
1996: Dieter Hoelzer; Nicola Gökbuget; R Arnold; Thomas Büchner; Mathias Freund; Winfried Gassmann; Gerhard Heil; Wolfgang Hiddemann; Helmut Löffler; T Lipp; Wolf-Dieter Ludwig; Georg Maschmeyer; Eckhard Thiel; D Messerer
[Acute lymphatic leukemia of the adult. Diagnosis, risk groups and therapy].
Der Internist 1996;37(10):994-1007.
1996: Dieter Hoelzer; Wolf-Dieter Ludwig; Eckhard Thiel; Winfried Gassmann; Helmut Löffler; Christa Fonatsch; Harald Rieder; Gerhard Heil; Barbara Heinze; R Arnold; Dieter K Hossfeld; Thomas Büchner; P Koch; Mathias Freund; Wolfgang Hiddemann; Georg Maschmeyer; Axel Heyll; Carlo Aul; T Faak; R Kuse; T H Ittel; M Gramatzki; Helmut Diedrich; K Kolbe; H G Fuhr; K Fischer; C Schadeck-Gressel; A Weiss; I Strohscheer; Bernd Metzner; U Fabry; Nicola Gökbuget; B Völkers; D Messerer; K Uberla
Improved outcome in adult B-cell acute lymphoblastic leukemia.
Blood 1996;87(2):495-508.
1994: H Link; Georg Maschmeyer; P Meyer; Wolfgang Hiddemann; W Stille; M Helmerking; D Adam
Interventional antimicrobial therapy in febrile neutropenic patients. Study Group of the Paul Ehrlich Society for Chemotherapy.
Annals of hematology 1994;69(5):231-43.
1994: Georg Maschmeyer; H Link; Wolfgang Hiddemann; P Meyer; M Helmerking; E Eisenmann; J Schmitt; D Adam
Pulmonary infiltrations in febrile patients with neutropenia. Risk factors and outcome under empirical antimicrobial therapy in a randomized multicenter study.
Cancer 1994;73(9):2296-304.
1994: Georg Maschmeyer; H Link; Wolfgang Hiddemann; P Meyer; M Helmerking; E Eisenmann; J Schmitt; D Adam
[Empirical antimicrobial therapy in neutropenic patients. Results of a multicenter study by the Infections in Hematology Study Group of the Paul Ehrlich Society].
Medizinische Klinik (Munich, Germany : 1983) 1994;89(3):114-23.
1993: Dieter Hoelzer; Eckhard Thiel; Wolf-Dieter Ludwig; Helmut Löffler; Thomas Büchner; Mathias Freund; Gerhard Heil; Wolfgang Hiddemann; Georg Maschmeyer; B Völkers
Follow-up of the first two successive German multicentre trials for adult ALL (01/81 and 02/84). German Adult ALL Study Group.
Leukemia 1993;7 Suppl 2():S130-4.
1993: Arnold Ganser; Gerhard Heil; K Kolbe; Georg Maschmeyer; J T Fischer; Lothar Bergmann; Paris S Mitrou; W Heit; H Heimpel; C Huber
Aggressive chemotherapy combined with G-CSF and maintenance therapy with interleukin-2 for patients with advanced myelodysplastic syndrome, subacute or secondary acute myeloid leukemia--initial results.
Annals of hematology 1993;66(3):123-5.
1993: Wolfgang Hiddemann; Carlo Aul; Georg Maschmeyer; R Schönrock-Nabulsi; Wolf-Dieter Ludwig; A Bartholomäus; P Bettelheim; K Becker; Leopold Balleisen; Bernd Lathan
High-dose versus intermediate dose cytosine arabinoside combined with mitoxantrone for the treatment of relapsed and refractory acute myeloid leukemia: results of an age adjusted randomized comparison.
Leukemia & lymphoma 1993;10 Suppl():133-7.
1993: Thomas Büchner; Wolfgang Hiddemann; Bernhard Wörmann; R Rottmann; Georg Maschmeyer; Wolf-Dieter Ludwig; Michael Zühlsdorf; K Buntkirchen; A Sander; J Aswald
The role of GM-CSF in the treatment of acute myeloid leukemia.
Leukemia & lymphoma 1993;11 Suppl 2():21-4.
1992: Thomas Büchner; Wolfgang Hiddemann; U W Schaefer; Helmut Löffler; Georg Maschmeyer; Wolf-Dieter Ludwig; Carlo Aul; Bernd Lathan; Achim Heinecke
Combined effect of very early intensification and prolonged post-remission chemotherapy in patients with AML.
Leukemia 1992;6 Suppl 4():68-70.
1992: Thomas Büchner; Wolfgang Hiddemann; Bernhard Wörmann; Helmut Löffler; Georg Maschmeyer; Dieter K Hossfeld; Wolf-Dieter Ludwig; M Nowrousian; Carlo Aul; U W Schaefer
Longterm effects of prolonged maintenance and of very early intensification chemotherapy in AML: data from AMLCG.
Leukemia 1992;6 Suppl 2():68-71.
1992: Dieter Hoelzer; Eckhard Thiel; Wolf-Dieter Ludwig; Helmut Löffler; Thomas Büchner; Mathias Freund; Gerhard Heil; Wolfgang Hiddemann; Georg Maschmeyer; B Völkers
The German multicentre trials for treatment of acute lymphoblastic leukemia in adults. The German Adult ALL Study Group.
Leukemia 1992;6 Suppl 2():175-7.
1991: Thomas Büchner; Wolfgang Hiddemann; Monika Koenigsmann; Michael Zühlsdorf; Bernhard Wörmann; A Boeckmann; E A Freire; G Innig; Georg Maschmeyer; Wolf-Dieter Ludwig
Recombinant human granulocyte-macrophage colony-stimulating factor after chemotherapy in patients with acute myeloid leukemia at higher age or after relapse.
Blood 1991;78(5):1190-7.
1991: Thomas Büchner; Wolfgang Hiddemann; G Löffler; Winfried Gassmann; Georg Maschmeyer; W Heit; Dieter K Hossfeld; H Weh; Wolf-Dieter Ludwig; Eckhard Thiel
Improved cure rate by very early intensification combined with prolonged maintenance chemotherapy in patients with acute myeloid leukemia: data from the AML Cooperative Group.
Seminars in hematology 1991;28(3 Suppl 4):76-9.
1991: Wolfgang Hiddemann; Carlo Aul; Georg Maschmeyer; R Schönrock-Nabulsi; Wolf-Dieter Ludwig; A Bartholomäus; P Bettelheim; K Becker; Leopold Balleisen; Bernd Lathan
High-dose versus intermediate-dose cytarabine combined with mitoxantrone for the treatment of relapsed and refractory acute myeloid leukemia: results of an age-adjusted randomized comparison.
Seminars in hematology 1991;28(3 Suppl 4):35-8.
1990: Wolfgang Hiddemann; Thomas Büchner; Gerhard Heil; K Schumacher; Helmut Diedrich; Georg Maschmeyer; Anthony Ho; M Planker; S Gerith-Stolzenburg; R Donhuijsen-Ant
Treatment of refractory acute lymphoblastic leukemia in adults with high dose cytosine arabinoside and mitoxantrone (HAM).
Leukemia 1990;4(9):637-40.
1990: Wolfgang Hiddemann; Norbert Schmitz; Michael Pfreundschuh; K H Pflüger; J Ollech-Chwoyka; C Tirier; Georg Maschmeyer; H Kirchner; T Wagner; P Koch
Treatment of refractory Hodgkin's disease with high-dose cytosine arabinoside and mitoxantrone in combination. Results of a clinical phase II study of the German Hodgkin Study Group.
Cancer 1990;66(5):838-43.
1990: Wolfgang Hiddemann; Eberhard Schleyer; C Uhrmeister; Carlo Aul; Georg Maschmeyer; Achim Heinecke; Thomas Büchner
High-dose versus intermediate-dose cytosine arabinoside in combination with mitoxantrone for the treatment of relapsed and refractory acute myeloid leukemia--preliminary clinical and pharmacological data of a randomized comparison.
Cancer treatment reviews 1990;17(2-3):279-85.
1990: T Buechner; Wolfgang Hiddemann; Monika Koenigsmann; M Zuehlsdorf; B Woermann; A Boeckmann; E Aguion Freire; G Innig; Georg Maschmeyer; Wolf-Dieter Ludwig
Recombinant human GM-CSF following chemotherapy in high-risk AML.
Bone marrow transplantation 1990;6 Suppl 1():131-4.
1990: Georg Maschmeyer; H Link; Wolfgang Hiddemann; P Meyer; M Helmerking; D Adam
Interventional antimicrobial strategy in febrile neutropenic patients. Results of a multicenter study in 1,260 patients with hematological malignancies. The Interventional Antimicrobial Strategy Study Group, Paul Ehrlich Society for Chemotherapy.
Onkologie 1990;13(1):38-42.
1990: Thomas Büchner; Wolfgang Hiddemann; Monika Koenigsmann; M Zuehlsdorf; B Woermann; A Boeckmann; E Aguion Freire; G Innig; Georg Maschmeyer; Wolf-Dieter Ludwig
Recombinant human granulocyte-macrophage colony-stimulating factor after chemotherapy for acute leukemias at higher age or after relapse.
Haematology and blood transfusion 1990;33():724-31.
1990: Wolfgang Hiddemann; H C Aul; Georg Maschmeyer; D Urbanitz; Bernd Lathan; A Reichle; H Köppler; R Donhuijsen-Ant; Wolf-Dieter Ludwig; T Grüneisen
Proposal for the classification of relapsed and refractory acute myeloid leukemias as the basis for an age-adjusted randomized comparison of sequentially applied high-dose versus intermediate-dose cytosine arabinoside in combination with mitoxantrone (S-HAM).
Haematology and blood transfusion 1990;33():604-10.
1990: Thomas Büchner; Wolfgang Hiddemann; S Blasius; P Koch; Georg Maschmeyer; C Tirier; H Sodomann; Rolf Kuse; Eckhard Thiel; Wolf-Dieter Ludwig
Adult AML: the role of chemotherapy intensity and duration. Two studies of the AML Cooperative Group.
Haematology and blood transfusion 1990;33():261-6.
1990: Thomas Büchner; Wolfgang Hiddemann; Georg Maschmeyer; W Ludwig; Helmut Löffler; M Nowrousian; Carlo Aul; Achim Heinecke
How to improve therapy for adult acute myeloid leukemia: studies of the AML Cooperative Group in the Federal Republic of Germany.
Journal of cancer research and clinical oncology 1990;116(1):97-9.
1989: Wolfgang Hiddemann; Carlo Aul; Georg Maschmeyer; Bernd Lathan; H Köppler; R Hoffmann; T Grüneisen; R Donhuijsen-Ant; Wolf-Dieter Ludwig; Leopold Balleisen
Age related randomized comparison of sequentially applied high-dose versus intermediate dose cytosine arabinoside in combination with mitoxantrone (S-HAM) in the treatment of relapsed and refractory acute myeloid leukemia: study design and preliminary results.
Onkologie 1989;12(1):4-6.
1987: Georg Maschmeyer; Wolfgang Hiddemann; H Kreutzmann; F Wendt
Combined chemotherapy with m-amsacrine in high-risk patients with acute non-lymphocytic leukemia.
Onkologie 1987;10(1):18-21.
1987: Thomas Büchner; D Urbanitz; Wolfgang Hiddemann; P Koch; H J Pielken; R Kuse; A Mohr; Georg Maschmeyer; H Kreutzmann; F Wendt
[Alternatives and further development of therapy of acute myeloid leukemia in adults. Update of West German multicenter studies].
Onkologie 1987;10(1):14-6.
1987: Thomas Büchner; Wolfgang Hiddemann; D Urbanitz; H Kreutzmann; Georg Maschmeyer; F Wendt; R Kuse; A Mohr; W Gassmann; Helmut Löffler
Postinduction and preremission chemotherapy alternatives for adult AML: three multicenter studies of the AML Cooperative Group.
Haematology and blood transfusion 1987;30():57-63.
1987: F Wendt; Georg Maschmeyer
Infection prevention and immediate antibiotic therapy in the neutropenic patient.
Haematology and blood transfusion 1987;30():175-81.
1986: Thomas Büchner; D Urbanitz; Wolfgang Hiddemann; P Koch; H J Pielken; R Kuse; A Mohr; Georg Maschmeyer; H Kreutzmann; F Wendt
[Acute myeloid leukemia (AML) in adults. Further development of therapy based on clinical phase II and phase III studies].
Onkologie 1986;9(2):83-91.